Context-Dependent Effects of Midkine on Plexiform Neurofibroma Growth and Drug Response in 3D Coculture Models
Ahmad Zunnu RainiD, Harini G. SundararaghavaniD, Kyungmin JiiD
Abstract
Midkine (MDK) is a heparin-binding growth factor that promotes tumor growth in many cancers and may contribute to type I neurofibromatosis (NF1) tumor by stimulating Schwann cell proliferation and supporting neurofibroma growth. Here, we investigated the role of midkine in plexiform neurofibroma with NF1 (pNF1) using both monoculture and neuron-tumor coculture system with biomimetic neuronal axons engineered to release midkine in 3D. In monoculture, midkine enhanced the growth of pNF1 tumor cells, consistent with its tumor-promoting role in several cancers. In contrast, in 3D coculture, midkine did not increase tumor growth and failed to alter response to selumetinib, the FDA-approved treatment for pNF1. These findings suggest that while midkine promotes tumor growth, its effect may be buffered or neutralized in a neuron-associated microenvironment, underscoring the importance of physiologically relevant models for evaluating therapeutic targets in NF1.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mechanical Stiffening Promotes Growth, Invasion, and Mitogen-activated protein kinase kinase (MEK) Inhibitor Resistance in 3D Plexiform Neurofibroma Cultures
Kyungmin Ji, Chenjun Shi, Jitao Zhang·bioRxiv·Mar 9, 2026
- Targeting NF-κB prevents Schwann cell reprogramming and plexiform neurofibroma initiation in mouse model of Nf1
Ramya Ravindran, Eui-Kyung Youn, … Nancy Ratner·bioRxiv·Nov 5, 2026
- SNX-2112 inhibits the ERBB3high tumor population in Plexiform Neurofibromas
Sajjad Ali Khan, Oluwatosin Aina, … Daochun Sun·bioRxiv·Apr 26, 2025
- Midkine Dependency Defines a Therapeutically Actionable Vulnerability in Medulloblastoma
Sridharan Jayamohan, Prabhakar Pitta Venkata, … Gangadhara R. Sareddy·bioRxiv·Apr 14, 2026
- Midkine Drives Reawakening of Dormant Melanoma Metastases
Carolina Rodríguez-Tirado, Thoufiqul Alam Riaz, … María Soledad Sosa·bioRxiv·May 27, 2025
- Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma
A. Thomaz, K. d. V. Pinheiro, … R. Roesler·bioRxiv·May 28, 2019